(Q44018962)

29 November 2017

Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis (English)

1 reference

29 November 2017

1 reference

Mamoru Fujita

1

1 reference

29 November 2017

Izumi Hayashi

2

1 reference

29 November 2017

Shohei Yamashina

3

1 reference

29 November 2017

Moritoshi Itoman

4

1 reference

29 November 2017

Masataka Majima

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Biochemical and Biophysical Research Communications

29 November 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 November 2017

294

1 reference

29 November 2017

441-447

1 reference

29 November 2017

2

1 reference

What Is the Evidence That Tumors Are Angiogenesis Dependent?

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Anti-angiogenesis: new concept for therapy of solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Angiogenesis in cancer, vascular, rheumatoid and other disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

The biology of vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Nonpeptide angiotensin II receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Tissue-localized angiotensin II enhances cardiac and renal disorders in Tsukuba hypertensive mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

The implications of angiogenesis for the biology and therapy of cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Analysis of experimental antiangiogenic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

Tumor angiogenesis: past, present and the near future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900496-5

10.1016/S0006-291X(02)00496-5

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference